Description

PRODUCT OVERVIEW

Cathelicidin Peptide Research

LL-37 belongs to a class of naturally occurring host-defense peptides investigated for their interactions with biological membranes and cellular signaling systems.

The mature peptide consists of 37 amino acid residues. Research has examined its structural behavior under different experimental conditions and its interactions with membrane models and selected cellular pathways.

These findings provide a scientific basis for controlled laboratory investigation but do not establish clinical efficacy or therapeutic suitability for the supplied material.

PRODUCT SPECIFICATIONS

Reference molecular information describes the unmodified LL-37 peptide. The exact chemical form, counterion, and analytical identity of the supplied material should be verified against its documentation.

SCIENTIFIC BACKGROUND

LL-37 is the mature C-terminal peptide fragment of the human cathelicidin precursor hCAP18, encoded by the CAMP gene. Its 37-residue sequence and positively charged character have made it a subject of extensive biochemical and biophysical investigation.

Published research has explored several aspects of LL-37, including:

· Peptide Structure: Investigation of its conformation and structural behavior in different experimental environments.

· Membrane Interactions: Analysis of peptide interactions with model lipid membranes.

· Innate Immune Signaling: Study of its interactions with selected cellular signaling pathways.

· Peptide Characterization: Examination of sequence identity, molecular mass, and chromatographic characteristics.

Experimental observations depend on the model system, concentrations, and study conditions. Findings from published studies should not be interpreted as evidence of clinical benefit or as confirmation of the characteristics of a particular commercial batch.

RESEARCH APPLICATIONS

LL-37 may be relevant to laboratory investigations involving:

· Antimicrobial Peptide Research: Characterization of peptide interactions in controlled experimental systems.

· Membrane Biophysics: Examination of peptide–lipid interactions using appropriate model membranes.

· Innate Immunity Research: Investigation of selected signaling pathways in experimental models.

· Structure–Function Studies: Analysis of relationships between peptide sequence, molecular structure, and observed laboratory properties.

· Analytical Characterization: Assessment of molecular identity and chromatographic purity.

· Comparative Peptide Studies: Evaluation of LL-37 alongside other peptide reference materials under defined research conditions.

These applications describe areas of scientific investigation and do not imply that the supplied product has been validated for any specific experimental outcome.

QUALITY & LABORATORY DOCUMENTATION

Products are supported by applicable third-party laboratory testing documentation. Independent verification and additional testing may be conducted where appropriate.

Researchers should review the documentation corresponding to the specific lot and confirm the reported peptide identity, analytical method, purity results, and other available quality measurements.

Chromatographic purity and molecular identity are separate analytical considerations. Neither should be assumed solely from the product label or catalog description.

LOT & BATCH REFERENCE

Where available, retain the lot number and corresponding Certificate of Analysis (COA) with laboratory records. Ensure that the document matches the product name, labeled quantity, and batch supplied.

Documentation for another peptide or a different product size should not be treated as verification of the material in hand.

STORAGE & HANDLING

Follow the supplier’s documented storage and handling requirements for the exact material supplied. Conditions may depend on the physical form, formulation, and packaging. Refer to the product label and applicable technical documentation for material-specific guidance.

RESEARCH USE STATEMENT

LL-37 5mg is offered strictly for laboratory research and analytical purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of any disease.

IMPORTANT NOTICE

Scientific literature describes LL-37 as a cathelicidin-derived peptide, but published findings do not independently establish the identity, purity, or suitability of a particular commercial batch. Verify the supplied material against its applicable product specifications and lot-specific analytical documentation before use in research.